Search Count: 51
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, KIZ, PG4, PEG, KZF |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.52 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, PGE, EDO, KJ6, 2OP, PG4, PEG, NHE, DMS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, EDO, KJN, NHE, PG4, PEG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, PEG, EDO, SHH, KK0, KZF, PG4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.56 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, PEG, PGE, KJF, NHE, PG4, EDO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: EDO, PG4, PEG, ZN, CA, NA, KKI, NHE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: PEG, PG4, EDO, ZN, CA, NA, KKW, KZF |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2022-09-21 Classification: TRANSCRIPTION Ligands: ZN, CA, NA, PEG, KRU, NHE, PG4, EDO |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, UMN |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, UNW |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UO5 |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UOH |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, EDO, UOE |
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UOW |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.63 Å Release Date: 2018-08-22 Classification: APOPTOSIS Ligands: ZN, FUK |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2018-08-22 Classification: APOPTOSIS Ligands: ZN, NA, FUE |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQT |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQW |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERZ |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EU2 |